CompletedNot Applicable

Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)

France800 participantsStarted 2013-03-21

Plain-language summary

Quantification and follow-up during 3 years of circulating tumoral DNA in patients with choroidal melanoma

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 18 years old or more. * Patient with a recent choroidal melanoma before the start of the specific treatment. * Patient able to stand a blood collection. * Work-up for extension (CT). * Patient explanation given and consent information signed or by legal representative Exclusion Criteria: * Patient without social protection / insurance. * Person deprived of liberty or under guardianship. * Inability to submit to medical monitoring of the trial for reasons of geography, social or psychological

What they're measuring

Assesment of the change of the circulating tumor DNA from baseline at 3 years

Timeframe: T0: before treatment; T1: 1 month after local treatment; T2: at 7 months; Tn : every 6 months up to 3 years.

Trial details

NCT IDNCT02875652

SponsorInstitut Curie

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-04-02

View on ClinicalTrials.gov More Choroidal Melanoma trials